FDA Inspection
Pharmaceutical Specialties, Inc.Pharmaceutical Specialties, Inc. – FDA Inspection, Aug 15, 2025
Record Details
This FDA Inspection record concerns Pharmaceutical Specialties, Inc., with an inspection on August 15, 2025, issued by the Minneapolis District Office, covering human drugs.
View Company Profile
ID · 2336d78e-7de4-4d30-aba2-d308c403a491
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1274911
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 211.84(d)(2)Component written specification
- 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
- 21 CFR 211.165(b)Microbiological testing
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.166(a)(3)Valid stability test methods
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Pharmaceutical Specialties, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 3, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 26, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 20, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pharmaceutical Specialties, Inc.
- FDA Inspection 1091169 - 2019-05-03
- FDA Inspection 867840 - 2014-02-26
- FDA Inspection 564154 - 2009-02-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.